Otsuka Bags Novel Antibody Tech, Pipeline In $430m Visterra Buy

 
• By Ian Haydock
  
Human antibody
OTSUKA BUILDS ANTIBODY EXPERTISE THROUGH VISTERRA PURCHASE • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business